Navigation Links
Prostate cancer clinical stage does not predict recurrence
Date:11/21/2010

A new study challenges the current staging system that determines the extent or severity of prostate cancer that has not metastasized. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that there is no link between localized prostate cancer's clinical stage and a patient's risk of cancer recurrence after having his prostate removed.

One of the primary purposes of staging prostate cancers is to help physicians determine a patient's prognosis. For example, a more advanced clinical stage should indicate a higher risk of cancer recurrence after treatment. Surprisingly, however, researchers have found that clinical stage is of questionable utility for predicting disease recurrence after surgical removal of the prostate (radical prostatectomy) in patients with localized prostate cancer.

Adam Reese, MD, of the University of California, San Francisco, and his colleagues questioned whether staging errors are responsible for this discrepancy. In other words, do physicians often inaccurately stage prostate cancer cases, and if so, does this account for the inconsistent reliability of clinical staging for predicting prostate cancer outcomes?

The investigators found that clinical stage was assigned incorrectly in 35.4 percent of 3,875 men in a multi-institutional national disease registry. The majority of these staging errors occurred because physicians frequently disregarded the results of transrectal ultrasound tests and incorrectly incorporated biopsy results when assigning stage.

Even after correcting these staging errors, however, there was no association between clinical stage and prostate cancer recurrence after radical prostatectomy. "Our findings question the utility of our current staging system for localized prostate cancer," said Dr. Reese.


'/>"/>

Contact: Jennifer Beal
healthnews@wiley.com
44-012-437-70633
Wiley-Blackwell
Source:Eurekalert

Page: 1

Related medicine news :

1. Medicare Panel Endorses Vaccine for Prostate Cancer Patients
2. New drug targets vitamin D receptors in hormone resistant prostate cancers
3. Multidisciplinary approach is key to successful treatment of aggressive prostate cancer
4. Prostate cancer treatment linked to higher rate of colon cancer, study finds
5. Colorectal cancer risk increases in prostate cancer patients on androgen deprivation therapy
6. Could a Prostate Cancer Treatment Raise Colon Cancer Risk?
7. Fracture Risk Seen With Hormone Therapy for Prostate Cancer
8. Use of Prostate Cancer Treatment Fell When Medicare Paid Docs Less
9. Scientists develop method to keep surgically-removed prostate tissue alive and working for week
10. Prognostic markers for prostate cancer patients who receive radiation after surgery
11. Targeted radiation therapy minimizes GI side effects for prostate cancer patients, Penn study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Alan Mozes HealthDay Reporter ... take note: Many American parents are aware of online physician-rating ... a pediatrician for their children, according to a new national ... than 1,600 parents -- further suggest that negative online ratings ... doctor has been recommended by a neighbor. Conversely, a ...
(Date:9/22/2014)... South Asians living in Canada have a higher rate ... compared with while people, McMaster researchers have found. ... Canadian Medical Association Journal (CMAJ Open) and may ... the fastest-growing ethnic groups in the country is the ... Canada, comprising about three percent of the population. They ...
(Date:9/22/2014)... 22, 2014. Kessler researchers have published a pilot ... wellness program in people with multiple sclerosis (MS). ... health, perceived stress, and pain. "Development and ... living with MS: Description and outcomes" was epublished ... International Journal of MS Care (doi: ...
(Date:9/22/2014)... 22, 2014 (HealthDay News) -- Two new prescription devices ... may provide some relief for people with migraine headaches ... new study. One device -- the Cefaly -- ... -- the Cerena -- is meant to be used ... release. "Patients have been looking for alternative migraine ...
(Date:9/22/2014)... weather can occur with little warning, so it’s important to be ... Month, Amica Insurance is offering the following tips to ... , Build an emergency supply kit. It should contain first-aid ... per person per day for at least 72 hours. , ... your family knows what to do and where to go if ...
Breaking Medicine News(10 mins):Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Higher risk of heart disease for South Asians in Canada 2Health News:Noninvasive Devices May Help Migraines, FDA Says 2Health News:Amica Shares Tips for National Preparedness Month 2
... UK after a successful bypass surgery in Delhi at a ... tourism.// ,Mavis Childs, 67, waited for more than two ... (NHS). But she opted for India when the operation was ... ,Childs, based in Wombourne, near Wolverhampton, says she traveled ...
... In a startling discovery, researchers have found that more ... several species that are popular pets. // , ... on Nov. 16), revealed that the symptoms like pain ... to the bacteria that thrive on bits of meat ...
... known as Kyolic may decrease the risk of heart ... to UK scientists.// ,Dr. Khalid Rhaman and colleagues ... supplementation of Kyolic brand aged garlic extract inhibits platelet ... blood clots. Clot formation inside healthy blood vessels is ...
... Another plant extract called Forskolin has been found to be ... cells in cultures and mice by up to 90 percent.// ... coleus forskohlii, a native of India that is used as ... plant in the US., ,CML, a malignant cancer of ...
... and Industry magazine says that tropical plants imported from ... and other related illnesses. // ,The Asian tiger ... this species was detected in the Netherlands leading to ... mosquitoes were detected in imported bamboo in a greenhouse ...
... some kinds of live mutated viruses can cure tumors in ... of Glasgow treated a patient with an aggressive //form of ... New Scientist reported. ,A mutation of the herpes virus ... four months to live in 1997. But, eight years later ...
Cached Medicine News:Health News:British Grandmother has timely bypass surgery in India 2Health News:More Lizards, Including Pets, Found Venomous 2Health News:Chronic Myelogenous Leukemia (CML) Has An Answer Now! 2Health News:Chronic Myelogenous Leukemia (CML) Has An Answer Now! 3
(Date:9/22/2014)... -- Research and Markets has announced ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - ... On the basis of type ... been divided into eight major segments, namely, light/laser, ... ablation technologies. The light/laser ablation technology segment accounted ...
(Date:9/22/2014)... 22, 2014  Olympus, a global technology leader ... and surgical procedures, among other core businesses, announced ... Munich -based Brainlab to be the ... This agreement applies to the US ENT market; ... and all distribution outside the U.S. The system, ...
(Date:9/22/2014)... 2014  Sutro Biopharma today announced that it has ... 2014,s Fierce 15 biotechnology companies, designating it as one ... industry.  "Sutro has earned some careful ... as industry partners for what promises to be a ... John Carroll , editor of FierceBiotech .  ...
Breaking Medicine Technology:Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 3
... 5 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... China , announced today that it,will release its financial results for ... of the market on Monday, August 16, 2010 . The ... at 8:00 a.m. ET to review,the Company,s financial ...
... Advanced Brain Technologies today announced results demonstrating that a modified ... Down syndrome. The results of the study, conducted in Nottingham, United ... of the article scheduled to appear in the journal Music and Medicine(i). ... It ...
Cached Medicine Technology:Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results 2Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results 3Results of Pilot Study Published in Journal Music and Medicine Reveal The Listening Program Helps Children With Down Syndrome Improve Speech Skills 2Results of Pilot Study Published in Journal Music and Medicine Reveal The Listening Program Helps Children With Down Syndrome Improve Speech Skills 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: